CEO Stephane Bancel has bought stock for the first time on the open market since he was named the top executive in October ...

A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price ...

Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

The S&P 500 has soared in recent times, delivering two consecutive years of double-digit gains, and investors -- from ...

For now, Moderna may be a good stock to put on a watch list, but it's likely too risky and volatile for the vast majority of ...

EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake challenges.

While the details surrounding the new virus are still unfolding, the market's reaction reflects concern over the potential ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.